Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Lamivudine 💬 1件: Lamivudine4件: COMBIVIR; Epivir; Lamivudine; Triumeq; --7件: 2, 26, 42, 46, 135, 265, 325 💬
2 Zidovudine 💬 1件: Zidovudine3件: COMBIVIR; Retrovir; Zidovudine; --6件: 25, 26, 135, 265, 325, 331 💬
3 Emtricitabine 💬 1件: Emtricitabine2件: Emtricitabine; TRUVADA; --4件: 25, 93, 265, 325 💬
4 Tenofovir 💬 1件: Tenofovir1件: Tenofovir; --6件: 2, 13, 25, 93, 265, 325 💬
5 Abacavir 💬 1件: Abacavir4件: Abacavir; Abacavir sulfate; Triumeq; Ziagen; --4件: 2, 135, 265, 325 💬
6 Baricitinib 💬 1件: Baricitinib2件: Baricitinib; OLUMIANT; 2件: JAK1,
JAK2 💬
35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬